Join Now

Author Archives: Natalie Themm

Ultradent Named a Fortune Magazine Top Workplace for Third Straight Year

By Natalie Themm | Published September 7, 2023

Ultradent Products is being recognized for the third consecutive year as a Fortune Magazine Top Large Workplace in Manufacturing and Production.

Posted in BioUtah News | Tagged | Comments Off on Ultradent Named a Fortune Magazine Top Workplace for Third Straight Year

BioTuesdays Features Halia Therapeutics CEO

By Natalie Themm | Published August 31, 2023

In a recent interview with BioTuesdays, Halia and Co-Founder David Bearss, P.HD., said that the company is “growing to become a leader in targeting the NLRP3 inflammasome through a unique mechanism of action.” Closely-held Halia Therapeutics is developing a broad pipeline of novel therapies that are essential mediators of immune cell signaling with the potential […]

Posted in BioUtah News | Tagged | Comments Off on BioTuesdays Features Halia Therapeutics CEO

BlueWind Medical’s Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence

By Natalie Themm | Published August 17, 2023

Revi redefines the treatment of Urgency Incontinence with a patient-centric implantable tibial neuromodulation solution that empowers patients

Posted in BioUtah News | Tagged | Comments Off on BlueWind Medical’s Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence

Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

By Natalie Themm | Published August 17, 2023

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians

Posted in BioUtah News | Tagged | Comments Off on Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

This plan to cut drug prices could result in lost jobs and fewer medicines

By Natalie Themm | Published August 17, 2023

By Kelvyn Cullimore For the Deseret News

Posted in BioUtah News | Tagged | Comments Off on This plan to cut drug prices could result in lost jobs and fewer medicines

Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

By Natalie Themm | Published August 17, 2023

Prolaris is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

By Natalie Themm | Published August 10, 2023

Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library. These advances were made possible by NVIDIA DGX Cloud supercomputing and the recent acquisition of Cyclica’s MatchMaker technology.

Posted in BioUtah News | Tagged | Comments Off on Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

Utah Company Developing Origami-inspired Technology Awarded NSF Grant to Advance Robotic Surgery

By Natalie Themm | Published August 10, 2023

August 7, 2023 Four years ago, Jacob Sheffield was building world-class carbon fiber travel guitars for adventurers journeying to places as remote as Everest and Antarctica. Ian Esplin was growing viruses in bioreactors and developing therapies to combat antibiotic-resistant pathogens. The two came together and co-founded Bloom Surgical with a goal to empower robotic surgeons […]

Posted in BioUtah News | Tagged | Comments Off on Utah Company Developing Origami-inspired Technology Awarded NSF Grant to Advance Robotic Surgery

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status

By Natalie Themm | Published August 10, 2023

Myriad Genetics announced enhancements to the GeneSight® Psychotropic test.

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status

Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment

By Natalie Themm | Published August 10, 2023

ComboMATCH study uses genetic testing to match advanced cancer patients with targeted treatments

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment

Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

By Natalie Themm | Published August 3, 2023

World leading, multi-disciplinary experts advise on adoption of FDA authorized KidneyintelX.dkd across 14 million US patients with diabetes and chronic kidney disease

Posted in BioUtah News | Tagged | Comments Off on Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

By Natalie Themm | Published August 3, 2023

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis […]

Posted in BioUtah News | Tagged | Comments Off on Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

A Special Thanks To Our Legacy and Platinum Elite Members